- Widely disseminated metastatic Ewing sarcoma: Sustained, complete metabolic response to first‐line oral metronomic chemotherapy
- ¿Puede la quimioterapia metronómica mejorar la sobrevida libre de progresión y sobrevida global en pacientes pediátricos con sarcomas avanzados?: Experiencia preliminar. Can metronomic chemotherapy improve PFS and OS in pediatric patients with advanced sarcomas ?
- A case of relapsing spinal atypical AT/RT responding to metronomic vinorelbine-cyclophosphamid-celecoxib.
- A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer
- A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic ewing sarcoma family of tumors
- Administration of temozolomide: comparison of conventional and metronomic chemotherapy regimens.
- Bevacizumab, With Sorafenib and Cyclophosphamide Provides Clinical Benefit for Recurrent or Refractory Osseous Sarcomas in Children and Young Adults
- Combination of metronomic cyclophosphamide and dietary intervention for neuroblastoma.
- Complete Remission and Long-term Survival in a Child With Relapsed Medulloblastoma With Extensive Osteosclerotic Bony Metastasis With a Novel Metronomic Chemobiological Approach.
- Cyclic Metronomic Chemotherapy for Pediatric Tumors: Six Case Reports and a Review of the Literature
- Desmoplastic small round cell tumors: role of metronomic maintenance
- Drug repurposing in pediatrics and pediatric hematology oncology.
- Effectiveness of metronomic chemotherapy in a child with medulloblastoma: A case report
- Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma
- Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach
- Infantile myofibromatosis: Small bumps pose big problems
- Intracranial desmoplastic small round cell tumor after childhood acute myeloid leukemia treated with metronomic oral cyclophosphamide
- Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical Trial
- Medication Errors on Oral Chemotherapy in Children With ALL in a Developing Country
- Metronomic Chemotherapy and Palliative Radiotherapy as Salvage Treatment of Refractory or Relapsed Pediatric Solid Tumors
- Metronomic Chemotherapy as a New Strategy for End-stage Pediatric Oncology Patients in Iran
- Metronomic Chemotherapy for Burkitt Lymphoma in a Patient With HIV
- Metronomic Chemotherapy for Pediatric Refractory Solid Tumors: A Retrospective Single-Center Study
- Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies
- Metronomic Chemotherapy in Progressive Pediatric Malignancies: Old Drugs in New Package
- Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial.
- Metronomic Maintenance Therapy in Refractory Acute Myeloblastic Leukemia with Monosomy 7
- Metronomic therapy for malignant peripheral nerve sheath tumor in NF1.
- Metronomic therapy in pediatric oncology: A snapshot.
- Metronomic Topotecan Sensitizes Crizotinib Antitumor Activity in Drug-Resistant Neuroblastoma Preclinical Models.
- Metronomics is as effective as current standard for recurrent high risk neuroblastoma
- More on propranolol and neuroblastoma
- Myelodysplastic syndrome-post-cytotoxic therapy for pediatric low-grade glioma
- Nontoxic, fiscally responsible, future of oncology: could it be beginning in the Third World?
- Oral etoposide and cyclophosphamide: A low-cost palliative metronomic chemotherapy in advanced pediatric cancers
- Oral Metronomic Maintenance Therapy Can Improve Survival in High-Risk Neuroblastoma Patients Not Treated with ASCT or Anti-GD2 Antibodies
- Oral Metronomic Topotecan Sensitizes Crizotinib Antitumor Activity in ALKF1174L Drug-Resistant Neuroblastoma Preclinical Models.
- Pharmacokinetics of metronomic temozolomide in cerebrospinal fluid of children with malignant central nervous system tumors
- Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children with relapsed/refractory solid tumors.
- Phase II metronomic Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma
- Propranolol a new drug against Rhabdomyosarcoma ?
- Propranolol in pediatric tumors : Presentation of 4 cases
- Radiation therapy and concurrent topotecan followed by maintenance triple anti-angiogenic therapy with thalidomide, etoposide, and celecoxib for pediatric diffuse intrinsic pontine glioma
- Response of Relapsed Pancreatoblastoma to a Metronomic Vinorelbine-Cyclophosphamide Combination
- Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment
- Results of the Latin American Pediatric Oncology Group (GALOP) Trial for Patients With Metastatic Ewing Sarcoma: Multicentric Study of Interval-Compressed Multiagent and Metronomic Chemotherapy
- Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
- Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells.
- SFCE-Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour
- Successful palliation of metastatic medulloblastoma with oral etoposide and risedronate
- Successful use of metronomic vinblastine and fluorothymidine pet imaging for the management of intramedullary spinal cord anaplastic oligoastrocytoma in a child.
- Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen A Nonrandomized Controlled Trial
- Terapia metronomica: una opcion para el control del cancer en pacientes en tratamiento de intencion no curativa
- Treatment of Langerhans cell histiocytosis with a modified risk-adapted metronomic protocol-experience from India.
- vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma: a multicentre, open-label, randomised, phase 3 trial.
